Jeffrey B. Kindler - 13 Mar 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
13 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 17:07:27 UTC
Previous filing
12 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KINDLER JEFFREY B Director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN /s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact 16 Mar 2026 0001174454

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +71,839 +55% 202,100 13 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Options Exercise -71,839 -100% $0.000000* 0 13 Mar 2026 Common Stock 71,839 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2 The RSUs vested in full on March 13, 2026.